Siv Helen Moen - Concepedia

Author

Siv Helen Moen

Norwegian University of Science and Technology

Also Known As

S H Moen, S. H. Moen, S.H. Moen, Siv H. Moen, Siv Helen Moen

Publications

785

Citations

H-Index

Concepts

All Affiliations

Norwegian University of Science and Technology St Olav's University Hospital University of Copenhagen Tsinghua University Peking University

About

Siv Helen Moen is an author at Norwegian University of Science and Technology specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	300
2	Cell Biology	4	4	300
3	Immunology	4	4	300
4	Autoimmunity	3	3	246
5	Pathology	1	1	72

Siv Helen Moen

Publications

711

Citations

H-Index

Page 1

	Year	Citations
Toll-like receptors mediate proliferation and survival of multiple myeloma cells Janne Ø. Bohnhorst, T. Rasmussen, Siv Helen Moen, Leukemia InflammationToll-like ReceptorsMolecular ImmunologyInnate Immune SystemImmunology	2006	146
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade Rui Yang, Samah Elsaadi, Kristine Misund, Journal for ImmunoTherapy of Cancer	2020	114
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss Muhammad Asif Zahoor, Marita Westhrin, Kristin Roseth Aass, Blood Advances ImmunologyImmune RegulationCell DeathPathologyImmune System	2017	72
Human Toll-like Receptor 8 (TLR8) Is an Important Sensor of Pyogenic Bacteria, and Is Attenuated by Cell Surface TLR Signaling Siv Helen Moen, Birgitta Ehrnström, June Frengen Kojen, Frontiers in Immunology	2019	70
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin Oddrun Elise Olsen, Karin Fahl Wader, Kristine Misund, Blood Cancer Journal SclerostinApoptosisImmunologyCell DeathTumor Biology	2014	54
Anti‐c‐<scp>MET</scp> Nanobody<sup>®</sup> – a new potential drug in multiple myeloma treatment Tobias S. Slørdahl, Tinneke Denayer, Siv Helen Moen, European Journal Of Haematology	2013	44
A Proviral Role for CpG in Cytomegalovirus Infection Ann‐Charlotte Iversen, Bjørg Steinkjer, Nadra Nilsen, The Journal of Immunology	2009	33
Toll-Like Receptor 8 Is a Major Sensor of Group B Streptococcus But Not Escherichia coli in Human Primary Monocytes and Macrophages Birgitta Ehrnström, Kai Sandvold Beckwith, Maria Yurchenko, Frontiers in Immunology	2017	31
Monoclonal immunoglobulins promote bone loss in multiple myeloma Marita Westhrin, Vlado Kovcic, Zejian Zhang, Blood	2020	30
The proportion of CD16<sup>+</sup>CD14<sup>dim</sup> monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma Anne‐Marit Sponaas, Siv Helen Moen, Nina‐Beate Liabakk, Immunity Inflammation and Disease ImmunologyImmune RegulationImmunotherapyTumor BiologyMyeloid Neoplasia	2015	28

Page 1